A new Amgen Inc. lung-cancer treatment, Lumakras, carried a hefty price tag when it came out in 2021: $17,900 per patient monthly. Just over a year later, in December 2022, a second drug for the ...

After several rounds of treatment for a rare eye cancer — weekly drug infusions that could cost nearly $50,000 each — Paul Davis learned Medicare had abruptly stopped paying the bills. That ...

New Drugs for Cancer, Rare Disease Can Now Cost More Than $20,000 a Month. Trend follows rising pressure on companies to rein in repeat or annual price hikes for older drugs. By .

$38,398 for a single shot of a very old cancer drug — and one "no-brainer" alternative By Arthur Allen October 26, 2022 / 5:00 AM EDT / Kaiser Health News ...

The recent, abrupt shortage of critical cancer drugs highlights a broken business model in generic drugs that leaves patients in the U.S. and all over the world more vulnerable to similar shortages.

So, Who Benefits From New Cancer Drugs? By Dennis Thompson HealthDay Reporter THURSDAY, Jan. 16, 2025 (HealthDay News) -- Cutting-edge targeted therapies are pushing back the line between life and ...

The drugs included in the price reductions treat a range of conditions, including cancer, diabetes and heart disease. The U.S. Department of Health and Human Services projects $1.5 billion savings ...